| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15,651 |
9,467 |
$965K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
22,170 |
13,063 |
$911K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,347 |
6,669 |
$706K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,156 |
4,677 |
$689K |
| 80053 |
Comprehensive metabolic panel |
58,927 |
46,930 |
$635K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,410 |
2,244 |
$507K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
24,184 |
4,899 |
$492K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,454 |
10,428 |
$474K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,466 |
10,438 |
$474K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
10,951 |
9,944 |
$439K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13,868 |
12,451 |
$409K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,048 |
4,113 |
$406K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
24,102 |
20,597 |
$401K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
57,133 |
44,642 |
$387K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31,991 |
17,082 |
$386K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,554 |
3,107 |
$345K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,477 |
2,276 |
$340K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
32,386 |
24,777 |
$256K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
21,629 |
17,857 |
$254K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
39,613 |
24,005 |
$247K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,696 |
13,320 |
$241K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,750 |
9,531 |
$216K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,245 |
7,737 |
$207K |
| T1015 |
Clinic visit/encounter, all-inclusive |
18,579 |
16,795 |
$196K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
923 |
792 |
$191K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
784 |
639 |
$186K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,191 |
1,053 |
$163K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,163 |
1,065 |
$162K |
| 86901 |
|
6,335 |
5,426 |
$155K |
| 71045 |
Radiologic examination, chest; single view |
19,493 |
16,815 |
$148K |
| J2704 |
Injection, propofol, 10 mg |
6,482 |
5,674 |
$129K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
967 |
827 |
$127K |
| 84484 |
|
17,315 |
12,239 |
$118K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,894 |
884 |
$115K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,523 |
10,507 |
$115K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,829 |
854 |
$114K |
| 83880 |
|
5,676 |
4,723 |
$113K |
| 87088 |
|
14,277 |
12,552 |
$113K |
| 87486 |
|
2,415 |
2,247 |
$109K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,840 |
1,679 |
$109K |
| 87581 |
|
2,413 |
2,246 |
$109K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,373 |
2,277 |
$109K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,617 |
11,541 |
$108K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,381 |
2,543 |
$107K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,416 |
2,248 |
$106K |
| 85027 |
|
21,422 |
18,139 |
$103K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,405 |
2,076 |
$103K |
| 81001 |
|
34,110 |
28,877 |
$101K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,208 |
9,848 |
$98K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,885 |
1,610 |
$95K |
| 82553 |
|
11,677 |
8,776 |
$94K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,825 |
6,594 |
$93K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,241 |
1,096 |
$87K |
| 36415 |
Collection of venous blood by venipuncture |
66,556 |
50,263 |
$81K |
| 82550 |
|
16,812 |
12,657 |
$79K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,110 |
2,003 |
$79K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,144 |
1,584 |
$78K |
| 80061 |
Lipid panel |
8,682 |
7,817 |
$77K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,171 |
1,034 |
$74K |
| 71046 |
Radiologic examination, chest; 2 views |
5,536 |
4,972 |
$74K |
| 80050 |
General health panel |
1,537 |
1,508 |
$71K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,798 |
5,909 |
$70K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,681 |
7,835 |
$69K |
| 83735 |
|
15,270 |
12,074 |
$68K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
18,386 |
14,595 |
$63K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,539 |
3,172 |
$63K |
| 74018 |
|
4,346 |
3,840 |
$62K |
| 82805 |
|
2,828 |
2,320 |
$62K |
| 84703 |
|
7,055 |
5,916 |
$61K |
| 36430 |
|
810 |
637 |
$60K |
| 87040 |
|
7,336 |
4,227 |
$60K |
| 87077 |
|
6,623 |
5,297 |
$60K |
| 82948 |
|
13,714 |
7,068 |
$59K |
| 81025 |
|
7,563 |
6,651 |
$58K |
| 97161 |
|
1,787 |
1,491 |
$57K |
| 87653 |
|
1,266 |
1,209 |
$56K |
| 86703 |
|
3,580 |
3,261 |
$56K |
| 96367 |
|
1,846 |
943 |
$56K |
| 59025 |
Fetal non-stress test |
374 |
279 |
$55K |
| 83690 |
|
8,093 |
6,945 |
$52K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,367 |
1,215 |
$49K |
| 86885 |
|
5,566 |
4,939 |
$48K |
| 86922 |
|
1,428 |
887 |
$47K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,201 |
973 |
$46K |
| 87807 |
|
3,875 |
3,488 |
$45K |
| 84439 |
|
7,255 |
6,391 |
$44K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
885 |
748 |
$44K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,964 |
5,110 |
$44K |
| 83605 |
|
5,418 |
4,343 |
$44K |
| 73564 |
|
1,814 |
1,430 |
$44K |
| 84702 |
|
4,355 |
3,415 |
$43K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,019 |
9,491 |
$42K |
| 82150 |
|
7,004 |
6,068 |
$42K |
| 84145 |
|
2,827 |
2,569 |
$42K |
| 87070 |
|
4,248 |
3,834 |
$41K |
| 86762 |
|
2,296 |
2,089 |
$38K |
| 73630 |
|
1,987 |
1,637 |
$37K |
| 72141 |
|
174 |
138 |
$37K |
| 85730 |
|
8,735 |
7,659 |
$37K |
| 73030 |
|
2,291 |
1,955 |
$37K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,947 |
5,392 |
$36K |
| 82677 |
|
1,066 |
1,010 |
$32K |
| 87340 |
|
2,779 |
2,535 |
$32K |
| 82105 |
|
1,583 |
1,482 |
$32K |
| 87186 |
|
5,471 |
4,358 |
$32K |
| 85610 |
|
11,121 |
9,261 |
$31K |
| 94760 |
|
3,605 |
1,945 |
$31K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
85 |
63 |
$31K |
| 73130 |
|
1,799 |
1,370 |
$30K |
| 94664 |
|
9,578 |
6,595 |
$30K |
| 70486 |
|
219 |
214 |
$29K |
| 72100 |
|
1,609 |
1,453 |
$28K |
| 74022 |
|
1,449 |
1,313 |
$27K |
| 86900 |
|
6,336 |
5,426 |
$26K |
| 73610 |
|
1,605 |
1,383 |
$26K |
| 83615 |
|
5,296 |
4,444 |
$24K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,366 |
2,270 |
$24K |
| 73221 |
|
117 |
98 |
$23K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
778 |
689 |
$23K |
| 93017 |
|
1,260 |
1,117 |
$23K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,966 |
5,095 |
$22K |
| 85379 |
|
2,720 |
2,460 |
$22K |
| 73562 |
|
952 |
749 |
$21K |
| 86336 |
|
1,065 |
1,009 |
$20K |
| 77066 |
Tomosynthesis, mammo |
377 |
361 |
$20K |
| 82565 |
|
2,505 |
2,011 |
$19K |
| 82728 |
|
2,077 |
1,763 |
$19K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,492 |
1,924 |
$19K |
| 76642 |
|
846 |
700 |
$19K |
| 93458 |
|
280 |
232 |
$18K |
| 86592 |
|
3,739 |
3,426 |
$18K |
| 82607 |
|
1,882 |
1,625 |
$18K |
| 95819 |
|
482 |
398 |
$18K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
99 |
80 |
$18K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,154 |
1,963 |
$17K |
| 20610 |
|
466 |
403 |
$17K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
79 |
66 |
$17K |
| 73502 |
|
1,258 |
1,036 |
$17K |
| 93971 |
|
511 |
449 |
$16K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
570 |
254 |
$16K |
| Q0247 |
Injection, sotrovimab, 500 mg |
13 |
12 |
$16K |
| 94729 |
|
981 |
851 |
$16K |
| 86677 |
|
1,391 |
1,253 |
$15K |
| 99152 |
|
2,850 |
2,468 |
$15K |
| 82248 |
|
3,332 |
2,658 |
$15K |
| 94726 |
|
996 |
862 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,310 |
1,194 |
$14K |
| 71250 |
|
176 |
160 |
$14K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
10,217 |
8,956 |
$14K |
| 94060 |
|
975 |
832 |
$14K |
| 83550 |
|
3,064 |
2,495 |
$14K |
| 90714 |
|
1,539 |
1,399 |
$13K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,276 |
905 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,035 |
1,485 |
$13K |
| 72040 |
|
665 |
602 |
$13K |
| 96376 |
|
4,748 |
3,319 |
$13K |
| 84153 |
|
994 |
916 |
$13K |
| 76937 |
|
541 |
465 |
$13K |
| 86803 |
|
773 |
719 |
$12K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
51 |
50 |
$12K |
| 80177 |
|
988 |
823 |
$12K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
407 |
259 |
$11K |
| 76000 |
|
809 |
747 |
$11K |
| 83540 |
|
3,303 |
2,709 |
$11K |
| 88342 |
|
372 |
310 |
$11K |
| 76801 |
|
320 |
288 |
$11K |
| 82950 |
|
1,813 |
1,736 |
$11K |
| 73110 |
|
618 |
538 |
$11K |
| 85660 |
|
1,634 |
1,485 |
$11K |
| 80076 |
|
1,842 |
1,573 |
$10K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,128 |
3,443 |
$9K |
| 97016 |
|
7,028 |
1,419 |
$9K |
| 80164 |
|
729 |
597 |
$9K |
| 81002 |
|
2,255 |
2,046 |
$8K |
| 85652 |
|
4,312 |
3,819 |
$8K |
| 71010 |
|
3,988 |
3,406 |
$8K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
227 |
61 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,267 |
7,176 |
$8K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,275 |
925 |
$8K |
| 76536 |
|
284 |
256 |
$8K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
4,583 |
1,179 |
$7K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
183 |
151 |
$7K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
85 |
63 |
$7K |
| 74220 |
|
181 |
169 |
$7K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,705 |
3,160 |
$7K |
| 71020 |
|
1,091 |
979 |
$7K |
| 84550 |
|
2,274 |
2,024 |
$7K |
| 95885 |
|
339 |
275 |
$7K |
| 82746 |
|
701 |
568 |
$7K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
33 |
30 |
$7K |
| 83970 |
|
465 |
417 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,583 |
1,434 |
$7K |
| 86140 |
|
1,566 |
1,301 |
$7K |
| J1953 |
Injection, levetiracetam, 10 mg |
259 |
213 |
$6K |
| 73560 |
|
399 |
313 |
$6K |
| 80069 |
|
1,406 |
1,170 |
$6K |
| 83021 |
|
312 |
279 |
$6K |
| 99153 |
Mod sedat endo service >5yrs |
1,358 |
1,184 |
$6K |
| 80074 |
|
126 |
113 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,974 |
6,899 |
$5K |
| 74420 |
|
225 |
207 |
$5K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
273 |
161 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
212 |
195 |
$5K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
282 |
253 |
$5K |
| 74000 |
|
1,344 |
1,192 |
$5K |
| 82947 |
|
1,100 |
987 |
$5K |
| 82570 |
|
1,285 |
1,074 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
244 |
187 |
$4K |
| 73590 |
|
220 |
196 |
$4K |
| 36600 |
|
2,558 |
2,184 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
129 |
110 |
$4K |
| 99215 |
Prolong outpt/office vis |
95 |
54 |
$4K |
| 72110 |
|
119 |
107 |
$4K |
| 85018 |
|
2,468 |
1,868 |
$4K |
| 77062 |
|
116 |
106 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,861 |
3,621 |
$4K |
| 36591 |
|
335 |
215 |
$3K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
161 |
141 |
$3K |
| 86038 |
|
331 |
293 |
$3K |
| 74178 |
|
44 |
30 |
$3K |
| 84100 |
|
1,879 |
1,455 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
8,776 |
6,970 |
$3K |
| 85014 |
|
1,697 |
1,243 |
$3K |
| 84481 |
|
240 |
217 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,548 |
2,264 |
$3K |
| 85045 |
|
763 |
596 |
$3K |
| 77065 |
Tomosynthesis, mammo |
57 |
55 |
$3K |
| 84156 |
|
914 |
748 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,135 |
2,232 |
$2K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
3,029 |
2,369 |
$2K |
| 76770 |
|
135 |
127 |
$2K |
| 85049 |
|
104 |
96 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
148 |
129 |
$2K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
252 |
221 |
$2K |
| 83655 |
|
145 |
119 |
$2K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
69 |
58 |
$2K |
| 84520 |
|
669 |
533 |
$2K |
| 93970 |
|
58 |
53 |
$2K |
| 77001 |
|
86 |
75 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,482 |
1,060 |
$2K |
| 96417 |
|
56 |
25 |
$2K |
| J1750 |
Injection, iron dextran, 50 mg |
28 |
27 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
295 |
227 |
$1K |
| 73140 |
|
104 |
86 |
$1K |
| 72190 |
|
60 |
52 |
$1K |
| 86696 |
|
36 |
30 |
$1K |
| C1769 |
Guide wire |
1,044 |
823 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
30 |
27 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
1,047 |
892 |
$1K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
233 |
169 |
$1K |
| 84480 |
|
102 |
89 |
$1K |
| 73700 |
|
13 |
12 |
$1K |
| 97162 |
|
55 |
49 |
$1K |
| 94761 |
|
132 |
64 |
$1K |
| 77080 |
|
12 |
12 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
368 |
320 |
$1K |
| 52005 |
|
17 |
12 |
$1K |
| 51610 |
|
59 |
56 |
$1K |
| 73552 |
|
92 |
66 |
$990.55 |
| 72170 |
|
55 |
51 |
$989.26 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
2,182 |
1,861 |
$915.49 |
| 97035 |
|
1,154 |
396 |
$902.62 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,377 |
1,230 |
$862.55 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,278 |
2,820 |
$732.67 |
| 87320 |
|
81 |
73 |
$720.72 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
16 |
13 |
$713.16 |
| 73090 |
|
44 |
37 |
$684.50 |
| 87210 |
|
176 |
152 |
$675.18 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
940 |
777 |
$667.46 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
80 |
59 |
$663.84 |
| 86695 |
|
36 |
30 |
$657.72 |
| J1956 |
Injection, levofloxacin, 250 mg |
117 |
98 |
$651.58 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
772 |
429 |
$629.02 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
2,218 |
1,875 |
$623.43 |
| 74021 |
|
36 |
27 |
$620.76 |
| 87205 |
|
133 |
111 |
$581.49 |
| 86704 |
|
48 |
45 |
$572.00 |
| 73080 |
|
42 |
39 |
$566.25 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
98 |
81 |
$517.23 |
| S0028 |
Injection, famotidine, 20 mg |
136 |
109 |
$494.68 |
| 86706 |
|
48 |
45 |
$479.89 |
| 78264 |
|
17 |
12 |
$471.90 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
107 |
80 |
$440.93 |
| 86431 |
|
92 |
80 |
$374.68 |
| 86160 |
|
25 |
13 |
$370.83 |
| 84132 |
|
175 |
141 |
$363.48 |
| 85007 |
|
351 |
304 |
$357.24 |
| 96415 |
|
104 |
66 |
$343.86 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
756 |
676 |
$338.98 |
| 84450 |
|
87 |
78 |
$332.25 |
| 85347 |
|
30 |
25 |
$332.13 |
| 84460 |
|
87 |
78 |
$331.73 |
| 87075 |
|
16 |
15 |
$305.01 |
| 97014 |
|
2,119 |
530 |
$273.14 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
190 |
156 |
$272.00 |
| 88300 |
|
46 |
42 |
$270.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
718 |
563 |
$261.93 |
| 74010 |
|
134 |
109 |
$261.84 |
| 87400 |
|
20 |
12 |
$243.30 |
| 86708 |
|
14 |
14 |
$230.83 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
241 |
210 |
$205.00 |
| 86200 |
|
16 |
14 |
$198.24 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
376 |
306 |
$179.35 |
| 94618 |
|
29 |
26 |
$164.58 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
404 |
289 |
$148.63 |
| 82010 |
|
30 |
24 |
$142.84 |
| 80320 |
|
13 |
12 |
$135.72 |
| 97166 |
|
59 |
51 |
$129.45 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
727 |
524 |
$128.10 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,169 |
1,007 |
$125.15 |
| J3480 |
Injection, potassium chloride, per 2 meq |
148 |
114 |
$119.97 |
| J1630 |
Injection, haloperidol, up to 5 mg |
108 |
99 |
$119.46 |
| 86705 |
|
13 |
13 |
$113.05 |
| 92611 |
|
26 |
25 |
$109.28 |
| 71101 |
|
13 |
12 |
$102.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
12 |
12 |
$93.72 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
31 |
26 |
$71.56 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
40 |
34 |
$65.32 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
339 |
246 |
$51.85 |
| 82043 |
|
13 |
13 |
$43.47 |
| 84134 |
|
19 |
18 |
$41.66 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
605 |
223 |
$40.45 |
| 0001A |
|
112 |
110 |
$33.11 |
| 0002A |
|
100 |
99 |
$31.60 |
| Q5105 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units |
330 |
143 |
$23.07 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
101 |
90 |
$22.02 |
| 96523 |
|
17 |
14 |
$20.94 |
| G0378 |
Hospital observation service, per hour |
1,256 |
1,199 |
$13.69 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
21 |
12 |
$12.40 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
14 |
12 |
$8.17 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
150 |
137 |
$3.52 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
122 |
114 |
$0.29 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
79 |
73 |
$0.18 |
| D7140 |
Extraction, erupted tooth or exposed root |
27 |
25 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
198 |
183 |
$0.00 |
| G0390 |
Trauma response team associated with hospital critical care service |
14 |
13 |
$0.00 |
| G1002 |
Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program |
630 |
538 |
$0.00 |
| 76942 |
|
72 |
65 |
$0.00 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
93 |
81 |
$0.00 |
| 0003A |
|
28 |
28 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
39 |
36 |
$0.00 |